Join the Diarrhea, Acute group to help and get support from people like you.
Diarrhea, Acute News
Related terms: Diarrhea, drug-induced
E. Coli Outbreak Tied to Raw Milk Cheese
MONDAY, Feb. 19, 2024 – Raw milk cheese tainted with E. coli bacteria has sickened 10 people in four states, hospitalizing four, federal regulators warn. The cases have been tied to Raw Farm brand...
CDC Investigating Illness Outbreak on Luxury Cruise Ship
Thursday, Feb. 8, 2024 – The U.S. Centers of Disease Control and Prevention is investigating an outbreak of gastrointestinal illness aboard a luxury cruise ship that sailed out of San Francisco on...
Climate Change Could Make Diarrheal Illness More Common
FRIDAY, Jan. 19, 2024 – People are more prone to coming down with a common gastrointestinal infection on hot, humid days, new research shows. The British study suggests that climate change and...
What's in the Water? Maybe Germs That Could Harm You
TUESDAY, July 4, 2023 – Under the surface of your favorite swimming pool, beach and lakes, hazards too small to be seen by the naked eye may await. And these bacteria, viruses and parasites can turn...
Allowing Bedside Nurses to Order C. Difficile Testing Cuts Time to Results
FRIDAY, May 26, 2023 – Allowing bedside nurses to independently order stool testing for Clostridioides difficile (C. difficile) significantly decreases the amount of time to receive test results...
Fecal Microbiota Transplantation Aids Resolution of Recurrent C. Difficile
TUESDAY, May 16, 2023 – For immunocompetent adults with recurrent Clostridioides difficile infection (rCDI), fecal microbiota transplantation (FMT) yields a significant increase in resolution...
FDA Medwatch Alert: Drug Safety Communication: Imodium (loperamide) for Over-the-Counter Use - FDA Limits Packaging To Encourage Safe Use
ISSUE: To foster safe use of the over-the counter (OTC) anti-diarrhea drug loperamide, FDA is working with manufacturers to use blister packs or other single dose packaging and to limit the number of...
FDA Medwatch Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets
ISSUE: Greenstone, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone...
FDA Approves Fulyzaq - First Anti-Diarrheal Drug for HIV/AIDS Patients
December 31, 2012 – The U.S. Food and Drug Administration today approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of...
Ask a question
To post your own question to this support group, sign in or create an account.